Förderprogramm · Italien
PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope.
PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. (Italien): 72 Förderungen in den letzten 24 Monaten an 36 Empfänger; eine typische Förderung beträgt etwa 77.000 €. Am häufigsten gefördert: Forschungs- und Entwicklungsprojekte. Datenstand: 17. November 2026, tägliche Aktualisierung.
- Förderungen der letzten 24 Monate
- 72
- Empfänger
- 36
- Summe, letzte 24 Monate
- ≈ 6.100.000 €
- Typische Förderung (Median)
- ≈ 77.000 €
- Offene Aufrufe
- 0
- Aufrufe auf der Seite
- 0
Offene Aufrufe
Noch keine Daten.
Neueste Förderungen
| Projekt | Empfänger | Förderbetrag | Datum |
|---|---|---|---|
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | TELEMEDICO DEVICE S.R.L. | 76.794 € | 27. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | HEALTHROPY SOCIETA' A RESPONSABILITA' LIMITATA IN SIGLA (HEALTHRO PY S.R.L.) | 128.490 € | 27. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | HEALTHROPY SOCIETA' A RESPONSABILITA' LIMITATA IN SIGLA (HEALTHRO PY S.R.L.) | 77.085 € | 27. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | TELEMEDICO DEVICE S.R.L. | 121.292 € | 27. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | LOGOIL S.R.L. | 37.773 € | 25. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | CORTICALE S.R.L. | 107.450 € | 25. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | CORTICALE S.R.L. | 40.050 € | 25. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | MECTROTECH S.R.L. | 36.792 € | 25. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | MECTROTECH S.R.L. | 107.517 € | 25. August 2026 |
| PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope. | LOGOIL S.R.L. | 123.610 € | 25. August 2026 |
Die meisten Förderungen erhielten
- LOGOIL S.R.L. 4
- Asg Superconductors S.P.A. 2
- MYWAI S.R.L. 2
- Generative Bionics S.R.L. 2
- PIXELSTUDIO SRL 2
- Hippocrates Sintech S.R.L. 2
- Healthropy Societa' a Responsabilita' Limitata in Sigla (Healthro Py S.R.L.) 2
- Telemedico Device S.R.L. 2
- Movendo Technology Societa' a Responsabilita' Limitata 2
- Spes Medica - S.R.L. 2
Wofür das Geld ist
Förderkalender
Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.
Fragen und Antworten
- PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope.: Wann starten die Förderaufrufe?
- Derzeit ist kein Aufruf offen.
- PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope.: Wie hoch ist eine Förderung?
- In den letzten 24 Monaten lag der Median bei etwa 77.000 €; 72 Förderungen, insgesamt etwa 6.100.000 €.
- PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope.: Wer erhält die Förderungen?
- Die meisten Förderungen der letzten 24 Monate: LOGOIL S.R.L. (4), ASG SUPERCONDUCTORS S.P.A. (2) und MYWAI S.R.L. (2).
- PR ERDF 2021-2027 – Action 1.1.1. Call “support for research and development projects in the area of health and life sciences under S3”. Amendment due to an increase of EUR 13.314.101,68 in the financial envelope.: Was wird gefördert?
- Am häufigsten: Forschungs- und Entwicklungsprojekte.